Singapore MAS Issues $92,700 (S$120,000) Insider Trading Fine on Singapore Medical Group Shareholder & Employee (Doctor) of Subsidiary Dr Chua Han Boon Kenneth Who was Approached as Shareholder to be Informed of Privatisation & Expansion Plan in 2022 Prior to Public Offer, Then-Singapore-Listed Singapore Medical Group Received Buyout Offer in 2022 September (13/9/26), Dr Chua Han Boon Kenneth Bought S$67,200 (210,000) of Shares on 6th & 7th September 2022 Before Buyout Offer, Dr Chua Han Boon Kenneth Volunteered Not to be Company Director or Management of Company for 2 Years
30th June 2026 | Hong Kong
The Monetary Authority of Singapore (MAS) has issued a $92,700 (S$120,000) insider trading fine on Singapore Medical Group shareholder & employee (Doctor) of subsidiary Dr Chua Han Boon Kenneth, who was approached as shareholder to be informed of privatisation & expansion plan in 2022 prior to public offer. The then-Singapore-listed Singapore Medical Group received buyout offer in 2022 September (13/9/26). Dr Chua Han Boon Kenneth bought S$67,200 (210,000) of shares on 6th & 7th September 2022, before the buyout offer. Dr Chua Han Boon Kenneth volunteered not to be company director or management of company for 2 years. Announcement (30/6/26): “he Monetary Authority of Singapore (MAS) has imposed a civil penalty of S$120,000 on Dr Chua Han Boon Kenneth (“Dr Chua”) for insider trading in the shares of Singapore Medical Group Limited (“SMGL”), which was listed on the Singapore Exchange at the time. On 13 September 2022, SMGL announced that it had received a voluntary conditional general offer (the “Offer”) by TLW Success Pte Ltd (the “Offeror”) to privatise SMGL. At the time, Dr Chua was a shareholder of SMGL and a doctor employed by one of SMGL’s subsidiary companies. Prior to SMGL’s announcement of the Offer, Dr Chua was one of the few shareholders approached by the Offeror and informed of the privatisation plan for SMGL, as well as of the intention to expand SMGL’s operations. Dr Chua was also asked to sign an irrevocable undertaking in favour of the Offer. While in possession of this material information about the Offer that was not yet publicly available, Dr Chua purchased a total of 210,000 SMGL shares on 6 and 7 September 2022 at a cumulative cost of S$67,200. Dr Chua admitted to contravening section 218(2)(a) of the Securities and Futures Act and has paid MAS the civil penalty without court action. Dr Chua has also given a voluntary undertaking not to be a company director or be involved in the management of a company for a period of two years. This civil penalty action against Dr Chua was the result of a joint investigation conducted by the Commercial Affairs Department (“CAD”) and MAS. The investigation was initiated following a referral from Singapore Exchange Regulation Private Limited.”
“ Singapore MAS Issues $92,700 (S$120,000) Insider Trading Fine on Singapore Medical Group Shareholder & Employee (Doctor) of Subsidiary Dr Chua Han Boon Kenneth Who was Approached as Shareholder to be Informed of Privatisation & Expansion Plan in 2022 Prior to Public Offer, Then-Singapore-Listed Singapore Medical Group Received Buyout Offer in 2022 September (13/9/26), Dr Chua Han Boon Kenneth Bought S$67,200 (210,000) of Shares on 6th & 7th September 2022 Before Buyout Offer, Dr Chua Han Boon Kenneth Volunteered Not to be Company Director or Management of Company for 2 Years “
![](https://www.caproasia.com/wp-content/uploads/2025/08/Air-Charter-Service-728x90-1.png")
(A) The civil penalty regime
A civil penalty action is not a criminal action and does not attract criminal sanctions. The civil penalty regime, designed to complement criminal sanctions and provide a nuanced approach to combat market misconduct, became operational at the beginning of 2004.Under section 232 of the SFA, MAS may enter into an agreement with any person for that person to pay, with or without admission of liability, a civil penalty for contravening any provision of Part 12 of the SFA. The civil penalty may be up to three times the amount of the profit gained or loss avoided by that person as a result of the contravention, subject to a minimum of $50,000 (if the person is not a corporation) or $100,000 (if the person is a corporation).
(B) Insider Trading under Section 218(2)(a) of the SFA
Section 218(2)(a) of the SFA prohibits a person who is in possession of materially price-sensitive information concerning a corporation (to which he is connected), which he knows is materially price-sensitive and not generally available, from (whether as principal or agent) subscribing for, purchasing, selling, or entering into an agreement to subscribe for, purchase or sell those securities of that corporation.
Singapore MAS Issues $92,700 (S$120,000) Insider Trading Fine on Singapore Medical Group Shareholder & Employee (Doctor) of Subsidiary Dr Chua Han Boon Kenneth Who was Approached as Shareholder to be Informed of Privatisation & Expansion Plan in 2022 Prior to Public Offer, Then-Singapore-Listed Singapore Medical Group Received Buyout Offer in 2022 September (13/9/26), Dr Chua Han Boon Kenneth Bought S$67,200 (210,000) of Shares on 6th & 7th September 2022 Before Buyout Offer, Dr Chua Han Boon Kenneth Volunteered Not to be Company Director or Management of Company for 2 Years
Caproasia Users
- Manage $20 million to $30 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2026 Investment Day
- March - Hong Kong
- March - Singapore
- April - Hong Kong
- April - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
